Rapportering på ledende medarbejderes transaktioner
Venligst se vedhæftede selskabsmeddelelse nr. 15 – 2019.Vedhæftet filSelskabsmeddelelse nr 15 – 2019
Year: 2019
Man Group PLC : Form 8.3 – Hansteen Holdings plc
Written by Customer Service on . Posted in Mergers And Acquisitions.
FORM 8.3PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1. KEY INFORMATION2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)All interests and all short positions should be disclosed.Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).(b) ...
ArcAroma AB: 191227 Godkänt patent i Japan
Written by Customer Service on . Posted in Public Companies.
Pressmeddelande 2019-12-27 ArcAroma har erhållit patent i Japan avseende bolagets kombinationsansökan. Tekniken är applicerbar inom flera områden såsom vattenrening, biogaseffektivisering, ballastvattenbehandling med mera. Den nya patentfamiljen beskriver hur olika biologiska partiklar effektivt selekteras ur ett flöde inför en behandling med CEPT® plattformen, vilket ger minskad belastning i biosteget och ökad effektivitet den tillhörande biologiska processen.ArcAromas patentombud, AWA, har meddelat att Japan nu har godkänt och meddelat patent avseende ytterligare en av bolagets patentansökningar. Det aktuella patentet skyddar särdragen hos den kombinationsbehandling som...
Fastsættelse af kuponrenter pr. 1. januar 2020 (EUR)
Written by Customer Service on . Posted in Public Companies.
DLR Kredit har fastsat kuponrenten for perioden 1. januar 2020 til 31. marts 2020 på følgende variabelt forrentede obligationer:ISIN-kode: DK000634425-4 Euribor3 2028 0,20 %ISIN-kode: DK000634727-3 Euribor3 2029 0,24 %Med venlig hilsenDLR Kredit A/SVedhæftet filRentefix20191227_EURO_DLR
AND (AND.AS) reaches agreement on a convertible loan of € 1million
Written by Customer Service on . Posted in Public Companies.
Capelle aan den IJssel, the Netherlands, 27 December 2019: AND International Publishers NV (“the Company” or “AND”) announces today that an agreement has been reached between the Company and a group of investors about a convertible loan of € 1million to be issued to the Company.Further details of the agreement will be finalized in the course of January 2020.About ANDAND is one of the few digital mapping companies offering seamless, worldwide coverage. AND’s focus is to create and deliver market leading, relevant, innovative and tailored location-aware content which fosters a safer and more sustainable world. Using smart technology, we constantly enrich and update our global data and offer an end-to-end portfolio of location-aware products and services.For more information contact:Thierry JaccoudCEOTel...
Ekso Bionics® udvider distributionen af EksoVest til Nordeuropa
Written by Customer Service on . Posted in Public Companies.
RICHMOND, Californien, Dec. 27, 2019 (GLOBE NEWSWIRE) — Ekso Bionics Holdings, Inc. (NASDAQ: EKSO), der er en af de førende udvikler af eksoskeletter til medicinsk og industriel brug, annoncerede i dag, at de har underskrevet en distributionsaftale med den største danskejede distributør af byggematerialer, BYGMA GRUPPEN A/S, for at gøre EksoVest tilgængelig i Nordeuropa.EksoVest er en bærbar fjederbaseret-teknologi til overkroppen, der er designet til at støtte brugerens arme, mens denne udfører opgaver over hovedhøjde. Ved at yde løftehjælp fra 2,2 – 6,8 kg pr. arm, reducerer EksoVesten belastningen og udmattelse for brugeren, hvilket reducerer den samlede risiko for skader. Derudover er brugerne i stand...
Ekso Bionics® baut den Vertrieb des EksoVest in Nordeuropa aus
Written by Customer Service on . Posted in Public Companies.
RICHMOND, Kalifornien, Dec. 27, 2019 (GLOBE NEWSWIRE) — Ekso Bionics Holdings, Inc. (NASDAQ: EKSO), ein führender Entwickler von Exoskeletten für medizinische und industrielle Anwendungen, gab heute die Unterzeichnung eines Vertriebsvertrags mit BYGMA GRUPPEN A/S, dem größten dänischen Baustoffvertriebshändler, bekannt, um das EksoVest-Exoskelett in Nordeuropa zu vermarkten.EksoVest ist eine am Oberkörper getragene Exoskelett-Technologie, die die Arme eines Arbeiters bei Überkopfarbeiten unterstützt. Dank der Hebehilfe von 2,2 bis 6,8 kg pro Arm verringert EksoVest die Belastung und Ermüdung der Arbeiter und senkt zugleich das allgemeine Verletzungsrisiko. Außerdem können die erforderlichen Arbeiten schneller bei gleicher oder besserer Qualität durchgeführt...
Sif preferred supplier for 33 Monopiles and 33 Transition Pieces
Written by Customer Service on . Posted in Public Companies.
For immediate releaseSif preferred supplier for 33 Monopiles and 33 Transition Pieces
CORRECTION: Oncology Pharma Receives LOI for Financing for US$ 38.4M from SCP Investment Partners, Ltd
Written by Customer Service on . Posted in Public Companies.
SAN FRANCISCO, CA, Dec. 26, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE – ONCOLOGY PHARMA, INC. (OTCPK: ONPH) is pleased to announce that it has received a letter of intent dated December 20th to facilitate a financing of US$ 38.4 Million from SCP Investment Partners, Ltd, UK. Financing is to be used to complete licensing agreements with Kalos Therapeutics for its lead anti-cancer bio-pharmaceutical (a peptide) medication, KTH-222. Kalos’ platform of peptide-based therapeutic drugs have internationally issued patents (EP 2 224 946 B1), along with a number of international patents pending. Also included in the financing is the completion of the licensing agreement with Ribera Solutions for its Connect2Med Application. Subject to a 90 day due diligence period.Oncology Pharma previously announced the execution of a Letter of...
INNSUITES HOSPITALITY TRUST (IHT) – DIVERSIFICATION, YTD PROFITS. THIRD QUARTER.
Written by Customer Service on . Posted in Public Companies.
Phoenix, AZ, Dec. 26, 2019 (GLOBE NEWSWIRE) — InnSuites Hospitality Trust (NYSE American: IHT) IHT reported fiscal third quarter revenues of approximately $1.50 million for the three months August 1, 2019 to October 31, 2019 up slightly from revenues of approximately $1.49 million for the same prior year period. Basic earnings per share for the three months ended October 31, 2019 was ($0.02) compared with $2.00 for the three months ended October 31, 2018, which reflected profitable asset sales.For the 12-month trailing periods November 1, 2018 to October 31, 2019, and November 1, 2017 to October 31, 2018, total revenue was approximately $6.5 million, up sharply from approximately $12.0 million in the prior 12-month period. Total reported earnings were approximately $658,000. This compared to earnings of approximately $8,274,000...
